Survival from rare cancer in adults: a population-based study.

[1]  M. Marangolo,et al.  Germ cell tumours of the testis. , 2005, Critical reviews in oncology/hematology.

[2]  Rossella Bertulli,et al.  Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial , 2004, The Lancet.

[3]  T. Treasure,et al.  Pleural mesothelioma: little evidence, still time to do trials , 2004, The Lancet.

[4]  Paul W Dickman,et al.  Regression models for relative survival , 2004, Statistics in medicine.

[5]  M. Coleman,et al.  EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  Z Wronkowski,et al.  European health systems and cancer care. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  M. Ballo,et al.  Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy , 2003, Cancer.

[8]  J. O'grady.  Treatment options for other hepatic malignancies , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[9]  R. Sainsbury.  Towards appropriate local surgery for patients with breast cancer , 2000, The Lancet.

[10]  L. Kiemeney,et al.  Gender differences in stage-adjusted bladder cancer survival. , 2000, Urology.

[11]  C. Haie-meder,et al.  Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma , 2000, Cancer.

[12]  P. Muti,et al.  The prognostic role of gender in survival of adult cancer patients. EUROCARE Working Group. , 1998, European journal of cancer.

[13]  F. Berrino,et al.  The EUROCARE II study , 1998 .

[14]  R. James.  Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin , 1996, The Lancet.

[15]  R. Berkowitz,et al.  Gestational trophoblastic disease , 1995, Cancer.

[16]  M. Coleman,et al.  Survival of cancer patients in europe—The EUROCARE study , 1995, Cancer Causes & Control.

[17]  R J McKenna,et al.  Clinical aspects of cancer in the elderly. Treatment decisions, treatment choices, and follow‐up , 1994, Cancer.

[18]  D. Gershenson.  Update on malignant ovarian germ cell tumors , 1993, Cancer.

[19]  T. Hakulinen,et al.  Cancer survival corrected for heterogeneity in patient withdrawal. , 1982, Biometrics.

[20]  B. Sischy,et al.  Definitive treatment of anal-canal carcinoma by means of radiation therapy and chemotherapy , 1982, Diseases of the colon and rectum.

[21]  P. Boyle.  Testicular cancer: the challenge for cancer control. , 2004, The Lancet. Oncology.

[22]  W. Ferguson,et al.  Childhood cancer: past successes, future directions. , 2002, Medicine and health, Rhode Island.

[23]  J. Miller,et al.  The surgical spectrum of pulmonary neuroendocrine neoplasms. , 2001, Chest.

[24]  H. Kaya,et al.  Prognosis and treatment of primary adenocarcinoma and adenosquamous cell carcinoma of the uterine cervix. , 2001, European Journal of Gynaecological Oncology.

[25]  E. Junor.  The impact of specialist training for surgery in ovarian cancer. , 2000, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.